Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
    • Lynch Syndrome
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal Care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events
    • Jeannie Ferris Recognition Award

Breast cancer

breast-mm cancer-types/breast-cancer/overview
    • Home
    • Types
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Statistics
    • Risk factors
    • Symptoms
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget’s disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Awareness
      • iPrevent
    • Diagnosis
      • Tests
        • Triple test
      • Stages of breast cancer
      • Receiving a diagnosis
      • Diagnosis of early breast cancer
      • Diagnosis of ductal carcinoma in situ
      • Diagnosis when breast cancer spreads
      • Questions to ask
    • Treatment
      • Treatment team
        • Members of the team
        • Talking with health professionals
        • Questions to ask
      • Deciding about treatment
        • Travelling
        • Pregnancy
        • Tips for making decisions
        • Questions to ask
        • MammaPrint ® (70 gene signature) test
      • Surgery
        • Breast-conserving surgery
        • Mastectomy
        • Surgery to the armpit (axilla)
        • Surgery for metastatic breast cancer
        • Breast reconstruction
        • Choosing a surgeon
        • Questions to ask
        • Care after surgery
      • Radiotherapy
        • Early breast cancer
        • Metastatic breast cancer
        • Questions to ask
        • Skin care
        • Travelling
      • Chemotherapy
        • How does chemotherapy work?
        • Type of chemotherapy
        • What does chemotherapy involve?
        • Side effects
        • Questions to ask
      • Hormonal therapies
        • Hormone receptors
        • Types of hormonal therapy
        • Side effects
        • Menopause and oestrogen production
        • Deciding about hormonal therapies
        • Questions to ask
      • Targeted therapies
        • HER2 receptors
        • Types of targeted therapy
        • Questions to ask
      • Complementary & alternative therapies
      • Palliative care
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
      • Follow-up
      • Advanced disease
        • When treatment stops
        • Facing the possibility of dying
        • Putting your affairs in order
        • Questions to ask
      • Recurrent and secondary cancer
    • Living with
      • Practical aspects of diagnosis
        • Costs of treatment and prostheses
        • Travel schemes
        • Questions to ask
        • Choosing a cancer treatment
      • Physical changes
        • Body image
        • Menopause
        • Fertility
        • Lymphoedema
      • Emotional changes
        • How you might feel
        • Effects on partners
        • Effects on children
        • Effects on family and friends
      • Physical changes – metastatic
        • Pain
        • Symptoms and treatment side effects
      • Emotional changes – metastatic
      • Practical aspects - metastatic
        • Work
        • Financial support
        • How to access support at home
        • How to access support outside home
        • Questions to ask
    • Life after
      • Health
        • Fatigue
        • Poor sleep
        • Lymphoedema
        • Menopause
        • Pain
        • Diet
        • Exercise
      • Feelings
      • Relationships
      • Practical issues
    • Support
    • Clinical trials
    • Health professionals
      • Menopausal symptoms
      • Screening
      • Breast cancer diagnosis
      • Early breast cancer
      • Metastatic breast cancer
      • Ductal carcinoma
      • Lobular carcinoma
      • GP guides and resources
      • Follow-up care
      • Breast cancer Qstream
    • Home
    • Types
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Statistics
    • Risk factors
    • Symptoms
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget’s disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Awareness
      • iPrevent
    • Diagnosis
      • Tests
        • Triple test
      • Stages of breast cancer
      • Receiving a diagnosis
      • Diagnosis of early breast cancer
      • Diagnosis of ductal carcinoma in situ
      • Diagnosis when breast cancer spreads
      • Questions to ask
    • Treatment
      • Treatment team
        • Members of the team
        • Talking with health professionals
        • Questions to ask
      • Deciding about treatment
        • Travelling
        • Pregnancy
        • Tips for making decisions
        • Questions to ask
        • MammaPrint ® (70 gene signature) test
      • Surgery
        • Breast-conserving surgery
        • Mastectomy
        • Surgery to the armpit (axilla)
        • Surgery for metastatic breast cancer
        • Breast reconstruction
        • Choosing a surgeon
        • Questions to ask
        • Care after surgery
      • Radiotherapy
        • Early breast cancer
        • Metastatic breast cancer
        • Questions to ask
        • Skin care
        • Travelling
      • Chemotherapy
        • How does chemotherapy work?
        • Type of chemotherapy
        • What does chemotherapy involve?
        • Side effects
        • Questions to ask
      • Hormonal therapies
        • Hormone receptors
        • Types of hormonal therapy
        • Side effects
        • Menopause and oestrogen production
        • Deciding about hormonal therapies
        • Questions to ask
      • Targeted therapies
        • HER2 receptors
        • Types of targeted therapy
        • Questions to ask
      • Complementary & alternative therapies
      • Palliative care
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
      • Follow-up
      • Advanced disease
        • When treatment stops
        • Facing the possibility of dying
        • Putting your affairs in order
        • Questions to ask
      • Recurrent and secondary cancer
    • Living with
      • Practical aspects of diagnosis
        • Costs of treatment and prostheses
        • Travel schemes
        • Questions to ask
        • Choosing a cancer treatment
      • Physical changes
        • Body image
        • Menopause
        • Fertility
        • Lymphoedema
      • Emotional changes
        • How you might feel
        • Effects on partners
        • Effects on children
        • Effects on family and friends
      • Physical changes – metastatic
        • Pain
        • Symptoms and treatment side effects
      • Emotional changes – metastatic
      • Practical aspects - metastatic
        • Work
        • Financial support
        • How to access support at home
        • How to access support outside home
        • Questions to ask
    • Life after
      • Health
        • Fatigue
        • Poor sleep
        • Lymphoedema
        • Menopause
        • Pain
        • Diet
        • Exercise
      • Feelings
      • Relationships
      • Practical issues
    • Support
    • Clinical trials
    • Health professionals
      • Menopausal symptoms
      • Screening
      • Breast cancer diagnosis
      • Early breast cancer
      • Metastatic breast cancer
      • Ductal carcinoma
      • Lobular carcinoma
      • GP guides and resources
      • Follow-up care
      • Breast cancer Qstream
  1. Home
  2. Statistics
Loading...

Breast cancer in Australia statistics

  • Printer-friendly version
  • A|A

The following material has been sourced from the Australian Institute of Health and Welfare

Breast cancer incorporates ICD-10 cancer code C50 (Malignant neoplasm of breast).


Estimated number of new cases of breast cancer diagnosed in 2022

20,640 = male icon 212 males + female icon 20,428 females


Estimated % of all new cancer cases diagnosed in 2022

12.7%


Estimated number of deaths from breast cancer in 2022

3,214 = male icon 36 males + female icon 3,178 females


Estimated % of all deaths from cancer in 2022

6.4%


Chance of surviving at least 5 years (2013–2017)

92%


People living with breast cancer at the end of 2017 (diagnosed in the 5 year period 2013 to 2017)

79,720


New cases

Breast cancer was the second most commonly diagnosed cancer in Australia in 2018. It is estimated that it will remain the second most commonly diagnosed cancer in 2022.

In 2018, there were 18,742 new cases of breast cancer diagnosed in Australia (205 males and 18,538 females). In 2022, it is estimated that 20,640 new cases of breast cancer will be diagnosed in Australia (212 males and 20,428 females). In 2022, it is estimated that a person has a 1 in 15 (or 6.7%) risk of being diagnosed with breast cancer by the age of 85 (1 in 668 or 0.15% for males and 1 in 8 or 13% for females).

 

estimated cancer incidence breast

Figure 1. Estimated cancer incidence in Australia, 2022

Notes

  • Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
  • More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)

In 2018, the age-standardised incidence rate was 67 cases per 100,000 persons (1.5 for males and 129 for females). In 2022, it is estimated that the age-standardised incidence rate will be 69 cases per 100,000 persons (1.4 for males and 131 for females). The incidence rate for breast cancer is expected to increase with age, highest for those aged 70–74 years.

age standardised breast cancer 2022

Figure 2. Age-standardised incidence rates for breast cancer, 1982 to 2018, by sex

Notes

  • Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
  • More information about incidence rates for breast cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)

The number of new cases of breast cancer diagnosed increased from 5,379 (61 males and 5,318 females) in 1982 to 18,742 in 2018. Over the same period, the age-standardised incidence rate increased from 44 cases per 100,000 persons (1.2 for males and 81 for females) in 1982 to 67 cases per 100,000 in 2018.

 

Deaths

In 2020, breast cancer was the fifth most common cause of cancer death in Australia. It is estimated that it will remain the fifth most common cause of death from cancer in 2022.

In 2020, there were 3,144 deaths from breast cancer in Australia (34 males and 3,110 females). In 2022, it is estimated that there will be 3,214 deaths (36 males and 3,178 females). In 2022, it is estimated that a person has a 1 in 105 (or 0.95%) risk of dying from breast cancer by the age of 85 (1 in 4,732 or 0.02% for males and 1 in 53 or 1.9% for females).

 

estimated-cancer-mortality-2022

Figure 3. Estimated cancer mortality in Australia, 2022

Notes

  • Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
  • More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)

 

In 2020, the age-standardised mortality rate was 10 deaths per 100,000 persons (0.2 for males and 19 for females). In 2022, it is estimated that the age-standardised mortality rate will be 9.7 deaths per 100,000 persons (0.2 for males and 18 for females). The mortality rate for breast cancer is expected to increase with age.

 

age standardised mortality 2022

Figure 4. Age-standardised mortality rates for breast cancer, 1982 to 2020, by sex

 

Notes

  • Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
  • More information about mortality rates for breast cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)

 

The number of deaths from breast cancer increased from 2,004 (17 males and 1,987 females) in 1982 to 3,144 in 2020. Over the same period, the age-standardised mortality rate decreased from 17 deaths per 100,000 persons (0.4 for males and 30 for females) in 1982 to 10 deaths per 100,000 in 2020. 

Survival

In 2014–2018, individuals diagnosed with breast cancer had a 92% chance (87% for males and 92% for females) of surviving for five years compared to their counterparts in the general Australian population. Between 1989–1993 and 2014–2018, five-year relative survival for breast cancer improved from 77% to 92%.

Figure 5. 5-year relative survival for breast cancer, 1989–1993 to 2014–2018, by sex

 

Notes

  • Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
  • More information about 5-year relative survival rates for breast cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Relative survival rate’ section (https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/5-year-relative-survival)

Prevalence

At the end of 2017, there were 17,507 people living who had been diagnosed with breast cancer that year, 79,720 people living who had been diagnosed with breast cancer in the previous 5 years (from 2013 to 2017) and 243,539 people living who had been diagnosed with breast cancer in the previous 36 years (from 1982 to 2017).

 

For more information, see Breast cancer on the NCCI website

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts.

  • Last Updated
  • Relevant Links
updated: 30 January 2023 - 3:26pm
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia